US/UK/Canada

Share

Pick a time period -
Tags ( Active)

HeartStitch ® PRESENTS PROGRESSIVE MULTI CENTER DATA AT THREE CONSECUTIVE CLINICAL CONGRESSES

HeartStitch® Receives Rave Reviews During Three Consecutive Clinical Congresses Presenting Multi-Center Data and Performing Live Cases.Fountain Valley, California—November 29, 2016—HeartStitch® continues to increase its presence in Interventional Cardiology with additional successful cases worldwide.  Recent Multi-Center clinical data presented at the TCT, CSI and GISE meetings in the US and Europe occurring between June and November.   Presentations have consecutively shown increased patient data at each meeting with the most recent data presented at the TCT (Transcatheter Cardiovascular

DR. MICHAEL MULLEN PRESENTS MULTI-CENTER CLINICAL DATA OF MORE THAN 100 NOBLESTITCH ™ EL PATIENTS AT MAJOR U.S. CARDIAC CONGRESS

Efficacy of the suture based NobleStitch™ EL  for Patent Foramen Ovale (PFO)Washington, DC—November 13, 2016 — Dr. Michael Mullen (Consultant Cardiologist, St. Bartholomew’s Heart Hospital, Chief Clinical Officer of HeartStitch) presented preliminary clinical data of PFO closure using the NobleStitch™ EL, in 112 patients,  at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) Congress held in Washington, DC. http://content.onlinejacc.org/article.aspx?articleid=2576007   Attendees from around the world gathered in the Nation’s Capital focusing on interventional cardiology

NobleStitch™ EL FEATURED AT ITALY'S GISE STRUCTURAL HEART CONGRESS IN GENOVA

Prof Giulio Speciale and Prof Achille Gaspardone Present the First Ever Italian Live Case of the NobleStitch™ EL Performed at the 2016 GISE Structural Heart Congress in Genova, ItalyRome, Italy—October 18, 2016 — In Rome, Italy a satellite transmission of PFO closure using only a single stitch, rather than a large metal implant, was performed live to an audience of more than 600 top cardiologists from around the world at the GISE Structural Heart Conference on Thursday.  The attendees witnessed the Live Case of percutaneous suture based closure of a PFO using the NobleStitch™ EL.  The case

HeartStitch ® Announces Expanded Intellectual Property Portfolio

New Allowance of Heart Valve Suturing Patent Significantly Increases HeartStitch’s International Intellectual Property PortfolioLos Angeles, California—September 7, 2016—HeartStitch® has been granted allowance of several critical new claims by the Japan Patent Office (JPO).  These claims will issue in Japan and are the latest building blocks in HeartStitch’s international strategy for remaining at the forefront of cardiac-device invention, design, and manufacture.    The issuance will directly relate to the HeartStitch® AP, and the suturing of anatomic valves percutaneously.  This

Nobles Medical Technologies II Unveils New Web Portal

New Portal Focuses On Serving Patients and Physicians While Showcasing Current And Future DevicesFountain Valley, California—September 6, 2016—Today Nobles Medical Technologies II (Nobles Med 2) launched a new web portal for both its U.S. and European markets, growing its ability to simultaneously dialogue with the world’s most forward-thinking cardiologists and cardiac surgeons—and their patients.  A multi level platform that provides more content, including patient )and physician testimonials

HeartStitch ® Presence In PFO Closure Hits New Milestone

Successful PFO Closures completed in Multiple Countries over one week using NobleStitch™ EL  Suture based system.Germany, Italy, Kazakhstan—September 6, 2016—HeartStitch® Inc, continues to increase its presence in Interventional Cardiology with continued successful cases worldwide. These recent cases proved that the NobleStitch™ EL system for PFO closure with it’s suture only technology is poised to be the device of choice for physicians around the world.  The devices were successfully used in over 20 patients, at 5 Heart Centers, by 6 doctors, in 3 countries over the one-week period.

NobleStitch ASD Closure Case Highlights Septal Defect Closure Revolution At CSI Conference

Prof. Nobles Presented Revolutionary First In Man Clinical Case Of ASD (Atrial Septal Defect) Closure And ASA (Atrial Septal Aneurysm) Repair At Structural Heart ConferenceFrankfurt, Germany—July 20, 2016—Nobles Medical Technologies II (NMT2) continued to surprise the more than 900 cardiologist and cardiac-specialist attendees at the CSI conference on structural heart interventions with its presentation of the first-ever ASA repair, ASD and PFO closure case.  Prof. Anthony Nobles, CEO and Chief Clinical Specialist of NMT2, presented the case in detail, highlighting its unique series

NobleStitch ™ PFO Multicenter Data Amplifies Renewed Interest at CSI Conference

Successful Multi-Center Data For NobleStitch™ EL Presented at Structural Heart Conference Highlights the Benefits of Device-less PFO ClosureFrankfurt, Germany—July 18, 2016—The expanded use of NobleStitch™ EL across many global markets has led to a steadily increasing body of data on real-world procedure outcomes. Dr. Michael Mullen presented the first multi-center data—collected across the UK, Sweden, Germany, Italy, and Kazakhstan—to the more than 900 cardiologists and cardiac specialist from around the world attending the CSI Structural Heart Conference in Frankfurt, Germany.  The data

Prof Horst Seivert Opens the 2016 CSI Structural Heart Congress by performing a live PFO closure case using Noblestitch EL

Prof Seivert successfully closes large PFO with a single suture in front of more than 500 top cardiologists from Europe.Frankfurt, Germany—June 23, 2016 — At the opening of the CSI Structural Heart Conference attendees witnessed a Live Case of percutaneous suture based closure of a PFO using the NobleStitch™ EL.  The case was transmitted live to the main auditorium of the Congress of Cardiac Specialists from around the world, who witnessed the successful closure of a PFO that was greater than a centimeter in diameter using only a single suture.  This real time exposure to the ease of use

Revolutionary New Heart Procedure Performed for t —Performed For T he First Time i I n Patients — Brings Worldwide Attention To Kazakhstan

HeartStitch®, Inc. aAnd National Cardiac Research Center In Astana Announced That It Has Performed The First In Man Transapical Access Procedure on Worldwide Premier Of First In Man Trans-Apical Access Closure With Minimally Invasive HeartStitch® Technology On Two PatientsAstana, Kazakhstan—June 29, 2016— New New medical technologies in medicine have alwayshave typically come to Kazakhstan from other countries. This all changed on June 14, 2016 when Dr. Y.V. Pya and his colleagues, along with renowned British Cardiologist Dr. Michael Mullen and medical -device inventor Prof. Anthony Nobles

HeartStitch™ Expanding Products’ Clinical Databases Across The Globe

Dr. Niels Erik-Nielsen Quickly Accumulating Diverse Case Histories With Ongoing Use Of HeartStitch’s NobleStitch™ ELLos Angeles, California—June 16, 2016—As one of Europe’s first interventional cardiologists to fully embrace the the benefits of HeartStitch’s NobleStitch™ EL device for PFO closure, Dr. Niels Erik-Nielsen has amassed significant experience with its use in a wide variety of situations.  His breadth of experience has been instrumental in building a growing body of international clinical evidence documenting HeartStitch® devices’ advantages.   Due to the number of

HeartStitch ® Announces Top New Sales and Marketing VP joins the HeartStitch Team

Highly Experienced Executive Will Fill Important Role Of Vice President, International Sales And MarketingLos Angeles, California—June 10, 2016—HeartStitch® is pleased to announce the appointment of Dirk Segers as Vice President, International Sales and Marketing.  Mr. Segers brings an extensive range of experience in the medical-device industry—spanning twenty-five years—to HeartStitch’s® international operations.   Based in Belgium, he has been tasked with developing the company’s sales and marketing activities world wide beginning in Europe, the Middle East, and Africa;

Nobles Medical Technologies II, Inc. Launches NobleStitch™ EL Sales in Germany With Five Successful Cases

Prof. Horst Sievert Performs Multiple ClosuresFrankfurt, Germany—June 8, 2016—Nobles Medical Technologies II, Inc. (NMT2) today announced that Prof. Dr. Horst Sievert of the Cardiovascular Center, Frankfurt successfully completed five PFO closures using the NobleStitch™ EL.  This marks the official sales release of the NobleStitch™ EL in Germany.   The first cases were performed in Germany last year by Dr. Michael Mullen and Prof. Sievert—one a week before the CSI Frankfurt Congress, and the second a live cased performed during the congress itself.  Subsequently, Prof. Sievert

HeartStitch® Unveils New Web Portal

Beta Release Focuses On Serving Patients and Physicians While Showcasing Current And Future DevicesFountain Valley, California—May 23, 2016—Today HeartStitch® launched a new web portal for both its U.S. and European markets, growing its ability to simultaneously dialogue with the world’s most forward-thinking cardiologists and cardiac surgeons—and their patients.  More than a pure marketing platform, HeartStitch.com was designed from the outset as a true portal that would serve cardiac patients searching for advanced surgical solutions, physicians looking to explore the latest

Nobles Medical Technologies II Receives Allowance Of Its Groundbreaking Patent For Next-Generation Suturing Device

NobleStitch™ QP Provides a Running Suture— A Key Element To Close Septal DefectsNobles Medical Technologies II (NMT2) today announced that it has received notice of allowance of its claims for its next-generation suturing technology.  With the issuance of this patent, NMT2 will expand its suture technologies to include the ability to remotely perform a running suture.  This technology will be applied to NMT2’s ASD-closure project currently under development.   Prof. Anthony Nobles, CEO of NMT2 and co-inventor on the allowed patent claims, commented, “This technology, which is

HeartStitch ® Launches German Sales of NobleStitch™ EL

Expansion Marked By First Five PFO ClosuresFrankfurt, Germany – May 2, 2016 – Prof. Dr. Horst Sievert of the Cardiovascular Center, Frankfurt, successfully completed five PFO closures using the NobleStitch™ EL—marking the official sales release of the NobleStitch™ device in Germany.   Dr. Michael Mullen, Cardiologist St. Bartholomew’s Hospital, London, and member of the HeartStitch® clinical advisory board, and Prof. Anthony Nobles, CEO of HeartStitch®—proctored Prof. Sievert and his team at the CVC Heart Center in Frankfurt on the NobleStitch™ EL PFO closure system.  This followed

HeartStitch ® Expands Sales of NobleStitch™ EL to Italy

Patient In Successful, First-Italian Case Avoids Nitinol Disc and Antiplatelet DrugsRome, Italy – April 19, 2016 – Prof. Cesare Greco, Associate Professor of Cardiology, Sapienza University of Rome consulting with renowned Prof. Carlo Gaudio of the Policlinico Umberto 1, Rome, Italy successfully performed the first-ever NobleStitch™ EL PFO closure in the country.  Reported in . This marks the official sales launch for HeartStitch® and its structural heart products in Italy.   HeartStitch® VP of Sales and Marketing Dirk Segers,

NobleStitch™ EL Sales Launch in Italy

First Italian NobleStitch™ EL Case Successfully PerformedRome, Italy—Tuesday, April 19, 2016— Nobles Medical Technologies II, Inc. (NMT2) today announced that Prof. Cesare Greco, Associate Professor of Cardiology, Sapienza University of Rome consulting with Prof. Carlo Gaudio of the Policlinico Umberto 1, Rome, Italy successfully performed the first ever suture based percutaneous PFO closure in Italy using the NobleStitch™ EL.  Reported in . This marks the official sales release of the NobleStitch™ EL in Italy.   Dr. Michael

Nobles Medical Technologies II Receives Significant Japanese Patent

For “SUTURING DEVICES AND METHODS FOR CLOSING A PATENT FORAMEN OVALE” Using It’s NobleStitch™ TechnologyFountain Valley, California—Wednesday, March 16, 2016— Nobles Medical Technologies II (NMT2) today announced that it has received another Patent for the NobleStitch™ Technology which provides coverage for its PFO device in Japan. The patent is for “Suturing Devices and Methods for Closing Patent Foramen Ovale (PFO)”. This patent provides NMT2 broad coverage of its method and apparatus claims for closing PFO in Japan; PFO closure is the core business of the NMT2 portfolio.   Prof.

There are no items matching the current filter
There are no more items matching the current filter
Back to top